Clinical Trial: Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma

Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational

Official Title: Content Validation of the EORTC QLQ-C30 Version 3.0, and NIH Quality of Life and Symptoms Questionnaire for Pheochromocytoma and Paraganglioma

Brief Summary: The purpose of this qualitative study is to evaluate the clarity and comprehensiveness of two disease-specific questionnaires, and to evaluate how effective these questionnaires are at assessing the quality of life and symptoms of patients with pheochromocytoma or paraganglioma.

Detailed Summary:
Sponsor: Molecular Insight Pharmaceuticals, Inc.

Current Primary Outcome: The main objective of this study is to evaluate content validity of the NIH Quality of Life and Symptoms Questionnaire for Pheochromocytoma and Paraganglioma and EORTC-QLQ-C30 in patients with pheochromocytoma or paraganglioma. [ Time Frame: Single Visit ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Molecular Insight Pharmaceuticals, Inc.

Dates:
Date Received: May 29, 2009
Date Started: April 2009
Date Completion:
Last Updated: June 7, 2013
Last Verified: June 2013